| __timestamp | Ionis Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 5903000 |
| Thursday, January 1, 2015 | 322292000 | 2762000 |
| Friday, January 1, 2016 | 344320000 | 1114000 |
| Sunday, January 1, 2017 | 374644000 | 25573000 |
| Monday, January 1, 2018 | 1820000 | 6000000 |
| Tuesday, January 1, 2019 | 4000000 | 38845000 |
| Wednesday, January 1, 2020 | 12000000 | 50523000 |
| Friday, January 1, 2021 | 11000000 | 75463000 |
| Saturday, January 1, 2022 | 14000000 | 105767000 |
| Sunday, January 1, 2023 | 9133000 | 167512000 |
| Monday, January 1, 2024 | 11215000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. offer a fascinating comparison. From 2014 to 2023, Ionis Pharmaceuticals experienced a significant fluctuation in its cost of revenue, peaking in 2017 with a 374 million USD expenditure. However, by 2023, this figure had decreased by approximately 98%, reflecting strategic cost management or shifts in operational focus.
Conversely, Xenon Pharmaceuticals Inc. has shown a steady increase in its cost of revenue, rising from a modest 6 million USD in 2014 to a substantial 168 million USD in 2023. This 2700% increase could indicate aggressive expansion or increased production costs.
These trends highlight the dynamic nature of the pharmaceutical industry, where companies must balance innovation with financial prudence to thrive.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Biogen Inc. vs Xenon Pharmaceuticals Inc.
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Bio-Techne Corporation and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Xenon Pharmaceuticals Inc.'s Expenses
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.